Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126207991 | 12620799 | 1 | I | 20160728 | 20160804 | 20160804 | EXP | US-UCBSA-2016028614 | UCB | KAVI T, MOLAIE D, NUROK M, ROSENGART A, LAHIRI S. PENTOBARBITAL-INDUCED MYOCARDIAL STUNNING IN STATUS EPILEPTICUS REQUIRING EXTRACORPOREAL MEMBRANE OXYGENATION: A CASE REPORT AND LITERATURE REVIEW. CASE REPORTS IN CRITICAL CARE. 2016 | 28.00 | YR | F | Y | 0.00000 | 20160804 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126207991 | 12620799 | 1 | PS | LACOSAMIDE. | LACOSAMIDE | 1 | UNK | U | U | 22253 | |||||||||
| 126207991 | 12620799 | 2 | SS | LACOSAMIDE. | LACOSAMIDE | 1 | U | U | 22253 | ||||||||||
| 126207991 | 12620799 | 3 | SS | LEVETIRACETAM. | LEVETIRACETAM | 1 | UNK | U | U | 0 | |||||||||
| 126207991 | 12620799 | 4 | SS | LEVETIRACETAM. | LEVETIRACETAM | 1 | U | U | 0 | ||||||||||
| 126207991 | 12620799 | 5 | C | PHENYTOIN. | PHENYTOIN | 1 | UNK | U | U | 0 | |||||||||
| 126207991 | 12620799 | 6 | C | MIDAZOLAM | MIDAZOLAMMIDAZOLAM HYDROCHLORIDE | 1 | UNK | U | U | 0 | |||||||||
| 126207991 | 12620799 | 7 | C | PROPOFOL. | PROPOFOL | 1 | U | 0 | |||||||||||
| 126207991 | 12620799 | 8 | C | LAMOTRIGINE. | LAMOTRIGINE | 1 | UNK | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126207991 | 12620799 | 1 | Status epilepticus |
| 126207991 | 12620799 | 2 | Off label use |
| 126207991 | 12620799 | 3 | Status epilepticus |
| 126207991 | 12620799 | 4 | Off label use |
| 126207991 | 12620799 | 5 | Seizure |
| 126207991 | 12620799 | 6 | Seizure |
| 126207991 | 12620799 | 7 | Seizure |
| 126207991 | 12620799 | 8 | Seizure |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126207991 | 12620799 | HO |
| 126207991 | 12620799 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126207991 | 12620799 | Drug ineffective for unapproved indication | |
| 126207991 | 12620799 | Off label use | |
| 126207991 | 12620799 | Status epilepticus |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |